9:22 AM
Leo Group India
| ||
| KV Pharmaceutical files for bankruptcy protection Reuters India CHICAGO (Reuters) - K-V Pharmaceutical, a Bridgeton-Missouri based company focused on women's healthcare products, filed for bankruptcy protection on Saturday, blaming federal actions that kept it from getting "full value" of a drug aimed at preventing ... See all stories on this topic » | ||
| Cipla to invest Rs 500 cr to set up API facilities Economic Times MUMBAI: Pharma major Cipla Ltd plans to invest Rs 500 crore for setting up an active pharmaceutical ingredients (API) facilities at Patalganga, Bengaluru and Kurkumbh. The setting up of these facilities is expected to be complete in 2012-13, the ... See all stories on this topic » | ||
| KV Pharmaceutical Files for Bankruptcy Protection Bloomberg K-V Pharmaceutical Co. (KV/A), a provider of women's health-care products, filed for bankruptcy after it said lax federal enforcement and state Medicaid restrictions prevented it from attaining the "full value" of a medicine intended to help pregnant ... See all stories on this topic » | ||
| Mylan Applauds Study Highlighting $1 Trillion in Savings for US Health Care ... Melodika.net (press release) Mylan Inc. (Nasdaq: MYL) today applauded a new study released by the Generic Pharmaceutical Association (GPhA) as further evidence of the savings and access that high quality, cost effective generic prescription drugs can bring to American consumers. See all stories on this topic » | ||
| Teva asthma, allergy drug approved by FDA Jerusalem Post Teva Pharmaceutical Industries Ltd.is one of ten companies to obtain US Food and Drug Administration (FDA) approval for a version of Merck's asthma and allergies drug Singulair in adults and children. Brand Singulair, made by Merck & Co., has $5 ... See all stories on this topic » | ||
| Shortage of drugs: NCB, DRA indifferent to patients' plight Business Recorder (blog) Sources said that during the last quota allocation meeting, the board allocated only two multinational pharmaceutical companies 2000-kilogram pseudo-ephedrine against their requirements of 29000kg. "That allocation of pseudo-ephedrine was just 25% of ... See all stories on this topic » | ||
| SEC opens Teva bribery probe Globes Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced that the US Securities and Exchange Commission (SEC) has subpoenaed documents related to the company's operations in Latin America. Teva added in its filing with the SEC that ... See all stories on this topic » | ||
| United States : AcelRx Pharmaceutical is further entitled for two new patents ... Equities.com ... "Small-Volume Oral Transmucosal Dosage Forms" issued to AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. See all stories on this topic » | ||
| AdvantaPure(R) to Highlight Molded Components, Single Use Products ... Melodika.net (press release) Sanitary tubing manufacturer AdvantaPure will showcase its single use items, molded manifolds and components, high purity tubing, and process hoses at several pharmaceutical and bioprocess events this fall. Each show will provide opportunities for ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment